Thus, our study revealed a previously unknown mechanism related to the positive regulation of breast cancer cell proliferation and survival involving the stabilization of ErbB2 by DEPTOR, suggesting that targeting DEPTOR via a variety of means might have therapeutic potential for the treatment of ErbB2-positive breast cancer. The gene discussed is ERBB2; the disease is breast cancer.